Advances in Neuroendocrine Cancer Metabolism
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".
Deadline for manuscript submissions: 15 June 2024 | Viewed by 355
Special Issue Editors
Interests: neuroendocrine tumors; neuroendocrine neoplasms; multiple endocrine neoplasia; medullary thyroid cancer; thyroid cancer; pituitary adenoma; parathyroid disease; pheocromocytoma and paraganglioma
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neuroendocrine neoplasms (NEN) are heterogeneous tumors with increasing incidence, arising from neuroendocrine cells throughout the body, and have the unique capacity to secrete bioactive molecules that can cause specific clinical syndromes. Dysregulated metabolism in cancer is of great relevance and a better knowledge of cell proliferation is essential to understand the mechanisms of tumor formation and cancer progression. Advances in neuroendocrine cancer metabolism may consider the patient’s entire clinical journey, from diagnosis to therapy. In NEN, different metabolic pathways are analyzed, and various positron emission tomography (PET) radiotracers and the analysis of different characteristic metabolic changes in tumor cells could be useful in identifying novel biomarkers of potential clinical use, improving diagnostic and patient outcomes, and designing tailored therapies.
Dr. Roberta Modica
Prof. Dr. Renata Simona Auriemma
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroendocrine neoplasms
- cancer metabolism
- metabolic alterations
- metabolic plasticity
- anticancer therapy
